CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Update in the Percutaneous Management of Coronary Chronic Total Occlusions Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation Hemodynamic Response to Nitroprusside in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Ejection Fraction Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials Screening for Atrial Fibrillation With ECG: USPSTF Recommendation 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures Astro-CHARM, the First 10-year ASCVD Risk Estimator Incorporating Coronary Calcium Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial New AHA/ACC/HRS Guidance on Sudden Cardiac Death Prevention
|<<... 3 4 5 6 7 8 9 ...>>|

Review Article2019 Jan 4. [Epub ahead of print]

JOURNAL：Eur Heart J. Article Link

Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization

Crea F, Bairey Merz CN, Beltrame JF et al. Keywords: Coronary microvascular dysfunction, Coronary spasm, Coronary stenosis, Percutaneous coronary intervention, Stable angina

ABSTRACT

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top